$BIOC changing of the guard means little when you've had three institutional investors buy up millions in stock since the beginning of 2020—at least in my opinion. There is no pattern of key personnel loss to speak of, so his departure is isolated and likely the result of healthy headhunting.
  • 2
  • 3